Daniel D. Gretler

2.1k total citations
43 papers, 1.6k citations indexed

About

Daniel D. Gretler is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Daniel D. Gretler has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 7 papers in Hematology. Recurrent topics in Daniel D. Gretler's work include Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Acute Myocardial Infarction Research (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Daniel D. Gretler is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Acute Myocardial Infarction Research (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Daniel D. Gretler collaborates with scholars based in United States, Canada and United Kingdom. Daniel D. Gretler's co-authors include Michael Murphy, Robert M. Scarborough, Uma Sinha, K. S. Nelson, Robert A. Harrington, Athiwat Hutchaleelaha, Matthew W. McClure, Paul Dorian, Mira Patel and Michael Gent and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Daniel D. Gretler

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel D. Gretler United States 20 1.1k 441 387 278 169 43 1.6k
M. Urooj Zafar United States 22 754 0.7× 442 1.0× 291 0.8× 206 0.7× 53 0.3× 60 1.5k
Jochen Graff Germany 18 598 0.5× 293 0.7× 348 0.9× 309 1.1× 43 0.3× 36 1.2k
Julio Osende United States 22 911 0.8× 677 1.5× 219 0.6× 247 0.9× 47 0.3× 46 1.8k
Rossana Lombardi Italy 16 437 0.4× 281 0.6× 171 0.4× 592 2.1× 129 0.8× 27 1.5k
Ernesto Paolasso Argentina 17 1.5k 1.4× 469 1.1× 329 0.9× 185 0.7× 42 0.2× 19 2.0k
Mattía Galli Italy 22 1.4k 1.3× 689 1.6× 296 0.8× 53 0.2× 52 0.3× 138 1.9k
Klaus Juul Denmark 14 280 0.3× 176 0.4× 213 0.6× 324 1.2× 64 0.4× 33 1.1k
H Wilkes United Kingdom 13 359 0.3× 197 0.4× 172 0.4× 464 1.7× 62 0.4× 16 1.3k
Jordi A. Matías‐Guiu Spain 10 1.2k 1.1× 340 0.8× 408 1.1× 61 0.2× 24 0.1× 23 1.8k
E Panak France 10 702 0.6× 317 0.7× 247 0.6× 148 0.5× 20 0.1× 14 1.1k

Countries citing papers authored by Daniel D. Gretler

Since Specialization
Citations

This map shows the geographic impact of Daniel D. Gretler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Gretler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Gretler more than expected).

Fields of papers citing papers by Daniel D. Gretler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Gretler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Gretler. The network helps show where Daniel D. Gretler may publish in the future.

Co-authorship network of co-authors of Daniel D. Gretler

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Gretler. A scholar is included among the top collaborators of Daniel D. Gretler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Gretler. Daniel D. Gretler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Peter, Vidya Perera, David H. Salinger, et al.. (2024). Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration. CPT Pharmacometrics & Systems Pharmacology. 13(9). 1462–1475. 2 indexed citations
2.
Salinger, David H., Maria Palmisano, Amy J. Sehnert, et al.. (2024). Recommendation of mavacamten posology by model‐based analyses in adults with obstructive hypertrophic cardiomyopathy. CPT Pharmacometrics & Systems Pharmacology. 13(9). 1448–1461. 2 indexed citations
3.
Perera, Vidya, et al.. (2023). Effects of Omeprazole and Verapamil on the Pharmacokinetics, Safety, and Tolerability of Mavacamten: Two Drug–Drug Interaction Studies in Healthy Participants. Clinical Pharmacology in Drug Development. 12(12). 1241–1251. 5 indexed citations
4.
5.
Howard, Jo, Claire Hemmaway, Paul Telfer, et al.. (2019). A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease. Blood. 133(17). 1865–1875. 84 indexed citations
6.
Sinha, Uma, Joel Morganroth, Daniel D. Gretler, Stanley J. Hollenbach, & Joseph L. Lambing. (2013). ABSENCE OF QTC PROLONGATION WITH BETRIXABAN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND POSITIVE-CONTROLLED THOROUGH ECG STUDY. Journal of the American College of Cardiology. 61(10). E271–E271. 1 indexed citations
7.
Connolly, Stuart J., John W. Eikelboom, Paul Dorian, et al.. (2013). Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa). European Heart Journal. 34(20). 1498–1505. 100 indexed citations
8.
Morganroth, Joel, Daniel D. Gretler, Stanley J. Hollenbach, Joseph L. Lambing, & Uma Sinha. (2012). Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study. Expert Opinion on Pharmacotherapy. 14(1). 5–13. 12 indexed citations
9.
Vavalle, John P., Susanna R. Stevens, Nancy Hassinger, et al.. (2011). The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trial. American Heart Journal. 162(6). 996–1002. 1 indexed citations
10.
Gurbel, Paul A., Kevin P. Bliden, Mark J. Antonino, et al.. (2009). The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19*2 genotype: first experience in patients. Journal of Thrombosis and Haemostasis. 8(1). 43–53. 68 indexed citations
11.
12.
Gretler, Daniel D., Roberto Guerciolini, & Paul J. Williams. (2004). Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function. Clinical Therapeutics. 26(3). 390–398. 28 indexed citations
13.
Jennings, Lisa K., Barbara E. Tardiff, David R. Phillips, et al.. (1998). Comparison of receptor occupancy and platelet aggregation response of eptifibatide administered intravenously in patients with unstable angina or non-Q-wave myocardial infarction. Journal of the American College of Cardiology. 31. 93–93. 3 indexed citations
14.
McClure, Matthew W., Lisa G. Berdan, Rodney Sparapani, et al.. (1998). Thrombocytopenia in a large, international trial of the GP IIb/IIIa inhibitor eptitibatide in patients with acute coronary syndromes. Journal of the American College of Cardiology. 31. 93–93. 5 indexed citations
15.
Gretler, Daniel D., et al.. (1994). Ethnic Differences in Circadian Hemodynamic Profile. American Journal of Hypertension. 7(1). 7–14. 91 indexed citations
16.
Gretler, Daniel D., et al.. (1993). Diurnal Blood Pressure Variability and Physical Activity Measured Electronically and by Diary. American Journal of Hypertension. 6(2). 127–133. 54 indexed citations
17.
Gretler, Daniel D., et al.. (1993). Low predictive value of positive Osler manoeuvre for diagnosing pseudohypertension.. PubMed. 7(1). 65–70. 6 indexed citations
18.
Murphy, Michael, et al.. (1991). Diurnal blood pressure variation: differences among disparate ethnic groups.. PubMed. 9(8). S45–7. 24 indexed citations
19.
Gretler, Daniel D., et al.. (1990). Cerebral blood flow during the acute therapy of severe hypertension with oral clonidine. The American Journal of Emergency Medicine. 8(4). 293–296. 23 indexed citations
20.
Elliott, W.J., et al.. (1990). Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.. Circulation. 81(3). 970–977. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Urooj Zafar Breakdown of academic impact, for papers by Jochen Graff Breakdown of academic impact, for papers by Julio Osende Breakdown of academic impact, for papers by Rossana Lombardi Breakdown of academic impact, for papers by Ernesto Paolasso Breakdown of academic impact, for papers by Mattía Galli Breakdown of academic impact, for papers by Klaus Juul Breakdown of academic impact, for papers by H Wilkes Breakdown of academic impact, for papers by Jordi A. Matías‐Guiu Breakdown of academic impact, for papers by E Panak
Rankless by CCL
2026